Our mission: Protect, Enhance and Save Lives
We are the world leader in particle accelerator technology. We design, produce and market innovative solutions for the diagnosis and treatment of cancer and other serious illnesses, and for industrial applications such as the sterilization of medical devices. Around the world, thousands of hospitals use particle accelerators and dosimetry equipment designed, produced, maintained and upgraded by IBA, in our mission to protect, enhance and save lives.
2000+
employees worldwide
World leader
in particle accelerator technology
Based in Belgium
offices in Canada, China, Germany, Russia and USA
From innovator to worldwide leader
Four core activities:
Proton Therapy Dosimetry RadioPharma Solutions Industrial Solutions
Continuing innovation
Our life-driven mission and the open relationships we have built with our customers and partners over time, together with our innovative mindset and our willingness to always strive for technological and scientific progress, make IBA a unique scientific company. We are characterized by a deep human connection that is illustrated by: Life, Science.
The IBA Discovery Lab: Pushing further disruptive ideas
At the heart of IBA’s commitment to innovation lies the Discovery Lab, an entity dedicated to exploring new horizons by leveraging IBA’s advanced technologies and expertise, beyond their current scope, in diverse applications.
Its mission: to foster early-stage innovation and develop groundbreaking projects that can address global challenges and untapped markets.
Stakeholder approach
We believe in a business model that creates shared and sustainable value for all stakeholders.
We believe in business as a force for good.
We are a certified B Corp.
IBA quality and EHS policies
At IBA, we are committed to develop, install and maintain safe, robust and compliant products for our customers worldwide.
— Olivier legrain, CEO
